Importantly, clinical and animal studies demonstrated that abnormal regulation of B2R‐VEGF, which results in impaired angiogenesis, contributes to increased blood pressure and peripheral resistance, ultimately leading to the development of myocardial hypertrophy and hypertension (Humar et al., 2009). This evidence concerns the gene VEGFA and cardiac hypertrophy.